Diana Fridlyand
Research
Publications
-
Uniting for Change: The GLOW Initiative and Its Impact on Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Pediatr Blood Cancer Volume: 72 Page(s): e31699
06/01/2025 Authors: Fridlyand DM; Keller F -
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
Neuro Oncol Volume: 26 Page(s): 348 - 361
02/02/2024 Authors: Johnson TS; MacDonald TJ; Pacholczyk R; Aguilera D; Al-Basheer A; Bajaj M; Bandopadhayay P; Berrong Z; Bouffet E; Castellino RC -
Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed Ligase IV Syndrome.
J Pediatr Hematol Oncol Volume: 45 Page(s): e139 - e141
01/01/2023 Authors: Fridlyand DM; Chandrakasan S; Aljudi A; Aumann WK; Westfall E; Kirwan B; Bryson EW; Keller FG; Arnold SD; Hong AL -
FIRST-IN-CHILDREN PHASE 1 TRIAL OF INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS: ANALYSIS OF SAFETY, TOLERABILITY, AND 5-YEAR OUTCOME
Volume: 24 Page(s): 68 - 68
11/01/2022 Authors: Johnson T; Pacholczyk R; Aguilera D; Al-Basheer A; Bajaj M; Bandopadhayay P; Berrong Z; Bouffet E; Castellino R; Dorris K -
Corrigendum to "MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system" [Pharmacology & Therapeutics 213 (2020) 107577].
Pharmacol Ther Volume: 225 Page(s): 107822
09/01/2021 Authors: Huelse JM; Fridlyand DM; Earp S; DeRyckere D; Graham DK -
MEK INHIBITION OVERCOMES STROMAL CELL-MEDIATED RESISTANCE TO MRX-2843, A DUAL MERTK/FLT3 INHIBITOR
Volume: 68 Page(s): S10 - S10
06/01/2021 Authors: Fridlyand D; Minson K; Vasileiadi E; Huey M; Wang X; Frye S; Earp HS; Graham D; DeRyckere D -
HSCT RESCUES MARROW FAILURE IN A PATIENT WITH LEUKEMIA AND PREVIOUSLY UNDIAGNOSED LIGASE IV SYNDROME
Volume: 68 Page(s): S198 - S199
06/01/2021 Authors: Fridlyand DM; Chandrakasan S; Aljudi A; Aumann W; Westfall E; Kirwan B; Bryson EW; Keller FG; Arnold SD; Hong AL -
HSCT RESCUES MARROW FAILURE IN A PATIENT WITH LEUKEMIA AND PREVIOUSLY UNDIAGNOSED LIGASE IV SYNDROME
Volume: 68 Page(s): S184 - S185
06/01/2021 Authors: Fridlyand D; Chandrakasan S; Aljudi A; Aumann W; Westfall E; Kirwan B; Bryson E; Keller F; Arnold S; Hong A -
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system.
Pharmacol Ther Volume: 213 Page(s): 107577
09/01/2020 Authors: Huelse JM; Fridlyand DM; Earp S; DeRyckere D; Graham DK -
Very late recurrence of B-cell acute lymphoblastic leukemia masquerading as a pituitary tumor.
Pediatr Hematol Oncol Volume: 37 Page(s): 438 - 444
08/01/2020 Authors: Fridlyand DM; Keller FG; Sabnis HS; Patterson BC; Gadde JA; Peragallo JH; Biousse V; Wechsler DS